Leadership Overview
Haleon has 10 executives leading key functions including strategy, marketing, and finance.
Driven by a commitment to consumer well-being, Haleon focuses on delivering trusted everyday health solutions through scientific innovation and a deep understanding of consumer needs, impacting global health markets.
Driven by a commitment to consumer well-being, Haleon focuses on delivering trusted everyday health solutions through scientific innovation and a deep understanding of consumer needs, impacting global health markets.
Leadership Roles at Haleon
Stevanus Budiawan - Chief Executive Officer
Stevanus Budiawan, the Chief Executive Officer at Haleon, directs the overarching corporate strategy and operational execution across all global markets. Budiawan guides the company's expansion in consumer healthcare, focusing on oral health, vitamins, minerals, and supplements, and over-the-counter remedies. This leadership role involves aligning research and development with market demands for brands like Sensodyne, Centrum, and Advil. Budiawan ensures that Haleon's product portfolio addresses critical consumer needs in respiratory, digestive, and pain management categories. By fostering innovation and strategic partnerships, Stevanus Budiawan drives the company's mission to deliver trusted everyday health solutions. The Chief Executive Officer's oversight extends to financial performance and sustainable growth initiatives, solidifying Haleon's market position through robust business practices and a clear vision for future development.
Anna Markova - Chief Financial Officer
Anna Markova, the Chief Financial Officer at Haleon, oversees all financial operations, including accounting, treasury, and investor relations. Markova manages the company's fiscal strategy, ensuring robust financial health and driving profitable growth across Haleon's diverse product lines, which span oral care, vitamins, and over-the-counter medications. This critical position involves meticulous budget management and resource allocation to support research, development, and global market expansion for brands such as Sensodyne, Centrum, and Advil. By implementing stringent financial controls and identifying strategic investment opportunities, Anna Markova safeguards the company's assets and enhances shareholder value. The Chief Financial Officer's expertise is vital in navigating complex global economic landscapes and ensuring the long-term financial stability of Haleon's operations in North America, Europe, and the Asia Pacific.
Mariam Catovic - Chief Marketing Officer & Project Manager
Mariam Catovic, the Chief Marketing Officer & Project Manager at Haleon, spearheads marketing initiatives and manages key strategic projects across the consumer healthcare portfolio. Catovic directs the development and execution of marketing campaigns for Haleon's extensive range of products, including oral health solutions like Sensodyne and Polident, and over-the-counter remedies such as Theraflu and Flonase. This dual role requires a keen understanding of market dynamics and project management discipline to ensure timely and effective product launches and brand enhancements. Catovic's leadership focuses on strengthening brand equity and expanding market reach in regions spanning North America, Europe, and Asia Pacific. By integrating marketing strategies with project timelines, Mariam Catovic ensures that Haleon's commitment to delivering trusted everyday health solutions resonates with consumers globally.
Katherine Raisley - Chief Marketing Officer, Business Process Lead
Katherine Raisley, the Chief Marketing Officer, Business Process Lead at Haleon, drives marketing strategy while optimizing internal business processes for enhanced efficiency. Raisley focuses on streamlining operations within the marketing function to support the global sale of consumer healthcare products, including oral care, vitamins, and OTC medications. This role involves analyzing and improving workflows for brand management and product development, ensuring seamless execution for brands like Advil, Centrum, and Sensodyne. Raisley's leadership ensures that marketing efforts are aligned with operational capabilities, contributing to Haleon's mission of providing accessible health solutions. By enhancing process efficiency, Katherine Raisley supports the effective delivery of products across North America, Europe, and the Asia Pacific markets, reinforcing Haleon's market presence.
Mohana Kalam - Manager - Chief Marketing Officer Technical Packaging SEAT
Mohana Kalam, the Manager - Chief Marketing Officer Technical Packaging SEAT at Haleon, manages technical aspects of packaging for marketing initiatives within the SEAT region. Kalam oversees the development and implementation of packaging solutions that align with marketing objectives and regulatory requirements for Haleon's diverse consumer healthcare products. This role is crucial for ensuring product integrity and consumer appeal for brands such as Voltaren, Panadol, and TUMS. Kalam's responsibilities include collaborating with marketing teams to translate brand strategies into effective packaging designs that meet technical specifications and market demands. By focusing on packaging innovation and quality, Mohana Kalam supports Haleon's commitment to delivering trusted and safe health products across its operational territories.
Jessica Ewan - Chief Marketing Officer & Business Analyst
Jessica Ewan, the Chief Marketing Officer & Business Analyst at Haleon, leads marketing efforts while providing critical business analysis to inform strategic decisions. Ewan analyzes market trends and consumer behavior to shape marketing strategies for Haleon's extensive product portfolio, encompassing oral health, vitamins, and over-the-counter medications. This dual focus ensures that marketing campaigns are data-driven and effectively target consumer needs for brands like Sensodyne, Emergen-C, and Flonase. Ewan's analytical insights guide product positioning and promotional activities across global markets, contributing to Haleon's mission of delivering trusted everyday health solutions. By bridging marketing execution with rigorous business intelligence, Jessica Ewan enhances the effectiveness and impact of Haleon's commercial strategies.
Michael Aiello - Chief Marketing Officer, Anz Quality Lead
Michael Aiello, the Chief Marketing Officer, Anz Quality Lead at Haleon, directs marketing strategies within the ANZ region while ensuring adherence to stringent quality standards. Aiello oversees the promotion of Haleon's consumer healthcare products, including oral care, vitamins, and OTC remedies, focusing on maintaining brand integrity and consumer trust. This role involves ensuring that all marketing activities in Australia and New Zealand align with global quality benchmarks and local market expectations for brands such as Advil, Centrum, and Otrivine. Aiello's leadership ensures that marketing messages accurately reflect product efficacy and safety. By integrating quality assurance with marketing execution, Michael Aiello supports Haleon's commitment to delivering reliable health solutions to consumers in the ANZ region.
Maria Del - Chief Marketing Officer, Innovation & Manager
Maria Del, the Chief Marketing Officer, Innovation & Manager at Haleon, drives marketing initiatives focused on product innovation and manages associated projects. Del leads the strategic development of marketing plans for new and improved consumer healthcare products, ensuring they meet evolving consumer needs in oral health, vitamins, and OTC categories. This role emphasizes bringing innovative solutions to market for brands like Parodontax, Caltrate, and Theraflu. Del's management ensures that innovation pipelines are effectively translated into compelling marketing narratives that resonate with target audiences across global markets. By championing innovation in marketing, Maria Del contributes significantly to Haleon's objective of providing advanced and trusted everyday health solutions.
Anurita Chopra - Head Chief Marketing Officer, Marketing, Sub-Continent (India)
Anurita Chopra, the Head Chief Marketing Officer, Marketing, Sub-Continent (India) at Haleon, leads all marketing operations for the Indian subcontinent. Chopra directs the strategic implementation of marketing campaigns for Haleon's diverse range of consumer healthcare products, including oral care, vitamins, and over-the-counter medications, tailored to the specific needs of the Indian market. This leadership role involves understanding regional consumer preferences and competitive landscapes to drive brand growth for products such as Sensodyne, Centrum, and Flonase. Chopra's focus is on enhancing brand visibility and market penetration within India. By aligning global marketing strategies with local insights, Anurita Chopra ensures Haleon's commitment to delivering trusted everyday health solutions effectively reaches consumers across the Sub-Continent.
Gustavo Serrano - Chief Marketing Officer
Gustavo Serrano, the Chief Marketing Officer at Haleon, directs comprehensive marketing strategies across key global markets. Serrano oversees the development and execution of campaigns for Haleon's extensive portfolio of consumer healthcare products, including oral health, vitamins, minerals, supplements, and over-the-counter remedies. This leadership position involves identifying market opportunities and consumer insights to drive brand growth for prominent brands such as Sensodyne, Centrum, and Advil. Serrano's focus is on enhancing brand equity and expanding market share through innovative promotional activities and strategic partnerships. By ensuring cohesive marketing efforts, Gustavo Serrano supports Haleon's mission to deliver trusted everyday health solutions to consumers worldwide.
Explore Leadership Teams in Manufacturing
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The company invests heavily in research and development, maintaining a robust pipeline of innovative medicines and diagnostic solutions while collaborating with academic institutions, biotechnology companies, and healthcare partners worldwide. Headquartered in Basel, Switzerland, Roche operates globally with a presence in numerous countries, employing a diverse workforce of scientists, researchers, healthcare professionals, and business experts dedicated to transforming patient care and making a meaningful difference in the fight against serious diseases.
Company Leadership IL
FB
NA
Jamjoom Pharma is one of the leading pharmaceutical companies in the Afrasia region focused on the Middle East, Africa, and CIS countries. Based in Jeddah, Saudi Arabia, Jamjoom Pharma manufactures and markets pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. The company is owned by the Jamjoom Group.
Company Leadership TH
NS
AM
AH
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan.
Company Leadership
CP
CO
GP
Morepen Laboratories is a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs) and finished formulations. With a commitment to quality and innovation, the company offers a wide range of healthcare, grooming, and OTC products under trusted brands like Dr. Morepen and Gubb World, catering to over 100 million consumers. Morepen has a robust global presence, exporting to over 80 countries and holding certifications from regulatory authorities such as USFDA and WHO GMP. The company is dedicated to enhancing lives through its extensive research and development efforts and state-of-the-art manufacturing facilities.
Company Leadership AS
PM
TA
Frequently Asked Questions Regarding Haleon Top Executives and Leadership Team
